Barclays Initiates Coverage On LivaNova with Overweight Rating, Announces Price Target of $105

Barclays analyst Christopher Pasquale has initiated coverage on LivaNova (NASDAQ: LIVN) with an Overweight rating. The firm has set a price target of $105 for the company's stock.